NCT02857361

Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.

An Open Label, Two-way Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols in Healthy Volunteers Under Fasted Conditions.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: iX Biopharma Ltd. · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The study will look at whether it is preferable to administer two wafers simultaneously or separately.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	Sublingual ketamine wafers	Two sublingual ketamine 25 mg wafers

Timeline

• Start date: 2016-07-01
• Primary completion: 2016-08-01
• Completion: 2016-08-01
• First posted: 2016-08-05
• Last updated: 2016-08-19

Locations

1 site across 1 country: Australia